NVAX
Novavax Inc
NASDAQ · Biotechnology
$8.25
+0.38 (+4.83%)
Open$8.01
Previous Close$7.87
Day High$8.31
Day Low$7.85
52W High$10.64
52W Low$5.01
Volume—
Avg Volume4.65M
Market Cap1.34B
P/E Ratio3.92
EPS$1.77
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+250.1% upside
Current
$8.25
$8.25
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 728.37M | 865.97M | 465.29M |
| Net Income | -200,198,760 | -214,218,147 | -6,820,545 |
| Profit Margin | -27.5% | -26.1% | -1.5% |
| EBITDA | -115,358,035 | -130,293,821 | -9,193,836 |
| Free Cash Flow | — | — | -7,451,233 |
| Rev Growth | -15.9% | -15.9% | +3.2% |
| Debt/Equity | 0.75 | 0.75 | 1.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |